9:00 a.m. Registration and Continental Breakfast 9:30 a.m. WELCOME 9:45 a.m. Parkinson’s Disease Roundtable to hear the latest in PD treatment and interventions from the PDMDC neurologists. This will be a moderated discussion on “Improving Quality of Life” with symptomatic treatments, disease-modifying therapies and pro-active living. There will be a questions and answers session with attendees following the panel discussion. Speakers: Tanya Simuni, MD; Cindy Zadikoff, MD and Danny Bega, MD. 10:45 a.m. Break 11:00a.m. NEW TREATMENT PIPELINE Cindy Zadikoff MD, MSc: Associate Professor of Neurology & Fellowship Director, Movement Disorders Neurology Clerkship Director Parkinson's disease and Movement Disorders Center Northwestern University 11:30a.m. The role of Exercise for People Living with Parkinson’s disease This discussion on exercise and physical activity will include information on the many options available and a summary of the research supporting how exercise can improve mobility and other Parkinson's-related symptoms Speaker: Miriam Rafferty, PT/DPT, PhD, Board Certified Neurologic Clinical Specialist 12:00 p.m. PHYSICAN PANEL: Question and Answer 12:30 p.m. Evaluation
|Effective start/end date||5/1/16 → 4/30/17|
- Teva Pharmaceuticals USA, Inc. (Check no. 10262074)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.